Identifying Potentially Profitable Stocks
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 23 2026
0mins
Source: Yahoo Finance
- Impinj Risk Analysis: Impinj (PI) has a trailing 12-month GAAP operating margin of -1.8%, with projected sales growth of only 9.3% over the next year indicating sluggish demand, and its forward P/E ratio of 64.7 suggests overvaluation, posing a risk of value destruction for investors.
- Myriad Genetics Financial Struggles: Myriad Genetics (MYGN) reports a GAAP operating margin of -46.9% over the past year, with annual revenue growth of just 3.5%, significantly below healthcare sector standards, and negative returns on capital indicate management's failure to generate profits while expanding, warranting caution from investors.
- Gevo Growth Potential: Gevo (GEVO) has achieved an impressive 19% annual revenue growth over the past decade, despite a GAAP operating margin of -2.9%, as its EBITDA profits and efficiency have improved due to fixed cost leverage, highlighting its competitive position in the renewable fuel market.
- Market Watch Recommendations: While Impinj and Myriad Genetics face significant challenges, Gevo's performance suggests potential long-term growth opportunities, making it a stock to watch for investors interested in sustainable aviation fuel market share expansion.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PI
Wall Street analysts forecast PI stock price to rise
8 Analyst Rating
7 Buy
1 Hold
0 Sell
Strong Buy
Current: 156.880
Low
200.00
Averages
240.50
High
273.00
Current: 156.880
Low
200.00
Averages
240.50
High
273.00
About PI
Impinj, Inc. (Impinj) is a RAIN radio frequency identification (RFID) and Internet of things provider. The Company helps businesses and people analyze, optimize, and innovate by wirelessly connecting billions of everyday things, such as apparel, automobile parts, luggage, and shipments to the Internet. The Impinj platform uses RAIN RFID to deliver timely data about these everyday things to business and consumer applications, enabling a boundless Internet of Things. It designs, sells or licenses, including silicon RAIN radios; manufacturing, test, encoding and reading systems, and software and cloud services that encapsulate its solutions know-how. The Company sells two types of silicon integrated circuit (IC), radios. The first are endpoint ICs that store a serialized number to wirelessly identify an item. The second are reader ICs that its partners use in finished readers to wirelessly discover, inventory and engage the endpoint ICs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Identifying Potentially Profitable Stocks
- Impinj Risk Analysis: Impinj (PI) has a trailing 12-month GAAP operating margin of -1.8%, with projected sales growth of only 9.3% over the next year indicating sluggish demand, and its forward P/E ratio of 64.7 suggests overvaluation, posing a risk of value destruction for investors.
- Myriad Genetics Financial Struggles: Myriad Genetics (MYGN) reports a GAAP operating margin of -46.9% over the past year, with annual revenue growth of just 3.5%, significantly below healthcare sector standards, and negative returns on capital indicate management's failure to generate profits while expanding, warranting caution from investors.
- Gevo Growth Potential: Gevo (GEVO) has achieved an impressive 19% annual revenue growth over the past decade, despite a GAAP operating margin of -2.9%, as its EBITDA profits and efficiency have improved due to fixed cost leverage, highlighting its competitive position in the renewable fuel market.
- Market Watch Recommendations: While Impinj and Myriad Genetics face significant challenges, Gevo's performance suggests potential long-term growth opportunities, making it a stock to watch for investors interested in sustainable aviation fuel market share expansion.
See More
Analysis of Risks and Opportunities in Small-Cap Stock Investments
- Impinj Stock Risks: Impinj (NASDAQ:PI), with a market cap of $4.52 billion, anticipates only 9.3% sales growth next year, indicating shaky demand, while historical operating margin losses reveal an inefficient cost structure and negative returns on capital, suggesting caution for investors.
- Gap's Stagnant Performance: Gap (NYSE:GAP), valued at $7.82 billion, has seen flat sales over the past three years, failing to expand its business, and its conservative store opening strategy reflects management's focus on improving existing locations, with a disappointing 7.6% return on capital indicating limited profitable growth opportunities.
- CoreCivic's Weak Growth: CoreCivic (NYSE:CXW), with a market cap of $1.94 billion, has muted annual revenue growth of 4.6% over the last five years, lagging behind peers, while its adjusted operating margin has fallen by 3.2 percentage points, and free cash flow margin has shrunk by 6.6 percentage points, suggesting increased capital consumption to remain competitive.
- Small-Cap Investment Warning: While small-cap stocks present investment opportunities due to limited Wall Street coverage, they also carry higher downside risks, necessitating careful selection to avoid stocks like Impinj, Gap, and CoreCivic to mitigate portfolio risk.
See More
Impinj Stock Surges 27% on Positive Q2 Outlook
- Stock Recovery: Impinj's stock has surged 27% since the April 29 earnings release, climbing from approximately $120 to $153 per share, reflecting increased investor confidence in the company's future prospects.
- Improved Profit Outlook: For the first time since Q2 2025, Impinj has guided for positive net income in Q2, projecting between $7.6 million and $9.1 million, exceeding analyst expectations and indicating signs of business recovery.
- Revenue Growth Expectations: The company anticipates Q2 revenue to reach between $103 million and $106 million, representing a 41% increase over Q1, suggesting that inventory issues have been resolved and demand is surging again.
- Market Reaction: Despite the stock's rebound, Impinj is still considered overvalued, trading at 74 times forward earnings, prompting investors to be cautious about the timing of potential buy-ins.
See More
Impinj Q1 Earnings Beat Expectations, Shares Surge 20.5%
- Earnings Surprise: Impinj reported Q1 2026 results with sales at $74.3 million, and although net losses increased from $0.30 to $0.83 per share, adjusted earnings of $0.14 exceeded market expectations of $0.11, demonstrating resilience amid challenges.
- Restocking Trend: As the supply chain works through excess inventory, Impinj's core customers are beginning to restock, with CFO Cary Baker noting that retail rebuys signal a recovery in market demand, providing momentum for future growth.
- New Product Launch: Impinj is ramping up production and shipments of a new series of RFID tags, which not only opens new growth opportunities but also enhances its competitive position in the market, potentially boosting sales further.
- Direct Customer Relationships: Impinj is establishing direct contracts with end users, which will improve revenue visibility and pricing power; despite the stock being 41% below its 52-week high, this strategic shift lays a foundation for future growth.
See More
Impinj Shares Surge 20% on Strong Q2 Outlook Exceeding Estimates
- Optimistic Outlook: Impinj expects Q2 revenue between $103M and $106M, representing a 7% year-over-year increase from $97.9M in Q2 2025, indicating strong performance and growth potential in the market.
- Earnings Expectations Raised: The company anticipates non-GAAP EPS between $0.77 and $0.82, surpassing the consensus estimate of $0.70, reflecting enhanced profitability and increased investor confidence.
- Solid Q1 Performance: For Q1 ended March 31, Impinj reported revenue of $74.3M, flat year-over-year but exceeding analyst expectations, demonstrating stability in a competitive market.
- Market Demand Recovery: With a rebound in endpoint IC demand, Impinj's management expresses optimism about future growth, emphasizing a proactive approach to capturing market share and achieving solution success despite macroeconomic uncertainties.
See More
Impinj Reports Strong Q1 2026 Earnings Exceeding Expectations
- Strong Performance: Impinj reported Q1 revenue of $74.3 million, exceeding expectations, with adjusted EBITDA also surpassing the upper end of guidance, indicating robust demand in the supply chain and logistics sectors.
- Market Share Growth: The company's market share increased by 1,700 basis points compared to 2024, reflecting sustained product demand amid retailer rebuys and lengthening competitor lead times.
- Cautious Outlook: While the second quarter is projected to generate revenue between $103 million and $106 million, management remains cautious about the second half of 2026 due to potential macroeconomic uncertainties.
- Commitment to Buybacks: Impinj opportunistically repurchased $40.2 million of convertible notes in March, demonstrating the company's commitment to minimizing dilution, which is expected to reduce the share count by approximately 400,000 shares.
See More
Identifying Potentially Profitable Stocks
- Impinj Risk Analysis: Impinj (PI) has a trailing 12-month GAAP operating margin of -1.8%, with projected sales growth of only 9.3% over the next year indicating sluggish demand, and its forward P/E ratio of 64.7 suggests overvaluation, posing a risk of value destruction for investors.
- Myriad Genetics Financial Struggles: Myriad Genetics (MYGN) reports a GAAP operating margin of -46.9% over the past year, with annual revenue growth of just 3.5%, significantly below healthcare sector standards, and negative returns on capital indicate management's failure to generate profits while expanding, warranting caution from investors.
- Gevo Growth Potential: Gevo (GEVO) has achieved an impressive 19% annual revenue growth over the past decade, despite a GAAP operating margin of -2.9%, as its EBITDA profits and efficiency have improved due to fixed cost leverage, highlighting its competitive position in the renewable fuel market.
- Market Watch Recommendations: While Impinj and Myriad Genetics face significant challenges, Gevo's performance suggests potential long-term growth opportunities, making it a stock to watch for investors interested in sustainable aviation fuel market share expansion.
See More
Analysis of Risks and Opportunities in Small-Cap Stock Investments
- Impinj Stock Risks: Impinj (NASDAQ:PI), with a market cap of $4.52 billion, anticipates only 9.3% sales growth next year, indicating shaky demand, while historical operating margin losses reveal an inefficient cost structure and negative returns on capital, suggesting caution for investors.
- Gap's Stagnant Performance: Gap (NYSE:GAP), valued at $7.82 billion, has seen flat sales over the past three years, failing to expand its business, and its conservative store opening strategy reflects management's focus on improving existing locations, with a disappointing 7.6% return on capital indicating limited profitable growth opportunities.
- CoreCivic's Weak Growth: CoreCivic (NYSE:CXW), with a market cap of $1.94 billion, has muted annual revenue growth of 4.6% over the last five years, lagging behind peers, while its adjusted operating margin has fallen by 3.2 percentage points, and free cash flow margin has shrunk by 6.6 percentage points, suggesting increased capital consumption to remain competitive.
- Small-Cap Investment Warning: While small-cap stocks present investment opportunities due to limited Wall Street coverage, they also carry higher downside risks, necessitating careful selection to avoid stocks like Impinj, Gap, and CoreCivic to mitigate portfolio risk.
See More
Impinj Stock Surges 27% on Positive Q2 Outlook
- Stock Recovery: Impinj's stock has surged 27% since the April 29 earnings release, climbing from approximately $120 to $153 per share, reflecting increased investor confidence in the company's future prospects.
- Improved Profit Outlook: For the first time since Q2 2025, Impinj has guided for positive net income in Q2, projecting between $7.6 million and $9.1 million, exceeding analyst expectations and indicating signs of business recovery.
- Revenue Growth Expectations: The company anticipates Q2 revenue to reach between $103 million and $106 million, representing a 41% increase over Q1, suggesting that inventory issues have been resolved and demand is surging again.
- Market Reaction: Despite the stock's rebound, Impinj is still considered overvalued, trading at 74 times forward earnings, prompting investors to be cautious about the timing of potential buy-ins.
See More
Impinj Q1 Earnings Beat Expectations, Shares Surge 20.5%
- Earnings Surprise: Impinj reported Q1 2026 results with sales at $74.3 million, and although net losses increased from $0.30 to $0.83 per share, adjusted earnings of $0.14 exceeded market expectations of $0.11, demonstrating resilience amid challenges.
- Restocking Trend: As the supply chain works through excess inventory, Impinj's core customers are beginning to restock, with CFO Cary Baker noting that retail rebuys signal a recovery in market demand, providing momentum for future growth.
- New Product Launch: Impinj is ramping up production and shipments of a new series of RFID tags, which not only opens new growth opportunities but also enhances its competitive position in the market, potentially boosting sales further.
- Direct Customer Relationships: Impinj is establishing direct contracts with end users, which will improve revenue visibility and pricing power; despite the stock being 41% below its 52-week high, this strategic shift lays a foundation for future growth.
See More
Impinj Shares Surge 20% on Strong Q2 Outlook Exceeding Estimates
- Optimistic Outlook: Impinj expects Q2 revenue between $103M and $106M, representing a 7% year-over-year increase from $97.9M in Q2 2025, indicating strong performance and growth potential in the market.
- Earnings Expectations Raised: The company anticipates non-GAAP EPS between $0.77 and $0.82, surpassing the consensus estimate of $0.70, reflecting enhanced profitability and increased investor confidence.
- Solid Q1 Performance: For Q1 ended March 31, Impinj reported revenue of $74.3M, flat year-over-year but exceeding analyst expectations, demonstrating stability in a competitive market.
- Market Demand Recovery: With a rebound in endpoint IC demand, Impinj's management expresses optimism about future growth, emphasizing a proactive approach to capturing market share and achieving solution success despite macroeconomic uncertainties.
See More
Impinj Reports Strong Q1 2026 Earnings Exceeding Expectations
- Strong Performance: Impinj reported Q1 revenue of $74.3 million, exceeding expectations, with adjusted EBITDA also surpassing the upper end of guidance, indicating robust demand in the supply chain and logistics sectors.
- Market Share Growth: The company's market share increased by 1,700 basis points compared to 2024, reflecting sustained product demand amid retailer rebuys and lengthening competitor lead times.
- Cautious Outlook: While the second quarter is projected to generate revenue between $103 million and $106 million, management remains cautious about the second half of 2026 due to potential macroeconomic uncertainties.
- Commitment to Buybacks: Impinj opportunistically repurchased $40.2 million of convertible notes in March, demonstrating the company's commitment to minimizing dilution, which is expected to reduce the share count by approximately 400,000 shares.
See More
